Newron Pharmaceuticals SpA, which has candidate products for pain and diseases of the central nervous system, has raised CHF 18.6 million (€15.2 million) in a share placement with institutional investors. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
